- Home
- ZLAB vs FMC Comparison
ZLAB vs FMC Comparison
Compare ZLAB & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | FMC |
|---|---|---|
| Founded | 2013 | 1910 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2017 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | FMC |
|---|---|---|
| Price | $18.37 | $14.05 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 13 |
| Target Price | ★ $49.44 | $17.75 |
| AVG Volume (30 Days) | 544.8K | ★ 2.8M |
| Earning Date | 05-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $460,156,000.00 | ★ $4,727,800,000.00 |
| Revenue This Year | $14.46 | $8.01 |
| Revenue Next Year | $29.47 | $4.81 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | N/A |
| 52 Week Low | $15.96 | $12.17 |
| 52 Week High | $44.34 | $44.77 |
Technical Indicators
Market Signals| Indicator | ZLAB | FMC |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 45.55 |
| Support Level | $16.77 | $12.85 |
| Resistance Level | $19.71 | $14.55 |
| Average True Range (ATR) | 0.76 | 0.75 |
| MACD | -0.11 | 0.01 |
| Stochastic Oscillator | 43.03 | 40.88 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.